Skip to main content

Dong Quai

Scientific Name(s): Angelica sinensis (Oliv.) Diels.
Common Name(s): Chinese angelica, Danggui, Dong quai, Tang-kuei

Medically reviewed by Last updated on Nov 30, 2022.

Clinical Overview


Dong quai is used in combination with other plant extracts in Chinese traditional medicine as an analgesic for rheumatism, an allergy suppressant, and in the treatment of menstrual disorders. Dong quai and its chemical constituents possess antiasthmatic, antispasmodic, anti-inflammatory, and anticoagulant properties. Clinical trials supporting traditional uses are limited. It has also been used to flavor liqueurs and confections.


Several forms of the plant exist and dosages vary widely: crude root extract by decoction ranges from 3 to 15 g/day; while in combination, preparations 75 mg to 500 mg may be taken up to 6 times a day.


Relative contraindications in patients receiving warfarin, heparin, or other anticoagulant/antiplatelet therapy, in those with breast cancer, or in the first trimester of pregnancy.


Avoid use. Uterine stimulant and relaxant activity have been reported with A. sinensis, while a related species, Angelica archangelica L., was a reported abortifacient and affected the menstrual cycle.


See Drug Interactions section.

Adverse Reactions

Case reports exist of fever, gynecomastia, and bleeding with concurrent warfarin use. A risk of photosensitization exists.


Data are limited. Chemical constituents have demonstrated cytotoxic properties.

Scientific Family

  • Apiaceae (carrot)


A. sinensis (Oliv.) Diels is synonymous with A. polymorpha var. sinensis (Oliv.). Three species of angelica are monographed separately in the Pharmacopoeia of the People's Republic of China: dong quai, the root of A. sinensis; bai zi, the root of Angelica dahurica (Fisch.) Benth. et. Hook. f. or A. dahurica var. formosana (Boiss.) Shan et Yuan; and du huo, the root of A. pubescens Maxim. f. biserrata Shan et Yuan. In Korea, A. gigas Nakai is used medicinally, while in Japan, A. acutiloba Kitagawa is used. The European A. archangelic L. is used to flavor liqueurs and confections. While botanically related, the various species of Angelica, which differ in chemistry, pharmacology, and toxicology should not be confused. A molecular biology study of A. acutiloba may lead to efficient methods for distinguishing raw materials.Tang 1992, Mizukami 1995


Dong quai has been used for thousands of years in traditional Chinese, Korean, and Japanese medicine and continues to be popular in China and elsewhere. It is used primarily for health issues in women and has been termed "female ginseng." It reported to be a blood strengthener and has been used for cardiovascular conditions, inflammation, headache, infections, and nerve pain.Medline 2009 It is also used to treat a wide range of conditions including menstrual disorders and other gynecological issues, as an analgesic in rheumatism, and in suppressing allergy symptoms. It is promoted for similar uses in the American herb market.Haines 2008


The chemistry of A. sinensis is distinct from that of other species in the genus. While coumarins have been reported from this speciesHata 1967 a recent comparative study of commercial dong quai products and related speciesZschocke 1998 found coumarins to be lacking, while the lactone Z-ligustilide was a major constituent.Chen 1984 In this study, A. sinensis more closely resembled Levisticum officinale in chemical composition than other species of Angelica. Thus, there is justification for terming the latter plant European dong quai. Several other lactones related to ligustilide have been found in A. sinensis.Sheu 1987, Hon 1990, Chen 1984 Ferulic acid and its esters were also found in A. sinensis. A capillary electrophoresis method for measuring ferulic acid in A. sinensis has been published.Ji 1999

In contrast, the roots of A. dahurica were found to contain an abundance of coumarins. Imperatorin and isoimperatorin are the major constituents, with many other related compounds (eg, bergapten, phellopterin, scopoletin) reported.Okuyama 1990 Ferulic acid was also detected in this species.Kwon 1997

The root of A. pubescens contains coumarins, but with some differences from A. dahurica. The simple prenylcoumarin, osthole, and the linear furocoumarins, columbianadin and columbianetin acetate, are the major constituents, while the coumarins, angelols A-H, are characteristic of the species.Kozawa 1980, Baba 1982

The common polyacetylene falcarindiol has been isolated from various species of Angelica.Zschocke 1998 Polysaccharides have been isolated from different species of Angelica; however, they have not been characterized sufficiently to permit comparison.Choy 1994 Simple plant sterols and lipids have also been found.Tani 1984 Reviews of the phytochemistry of Radix A. sinensis have been published.Chen 2013, Wei 2016

Uses and Pharmacology

Dong quai is widely used in the United States to treat hot flashes and other symptoms of menopause, despite a lack of clinical data. Results from studies evaluating dong quai’s estrogenic effects have been conflicting, possibly due to differences in the preparations studied, and there is some data to suggest serotonergic activity.(Hajirahimkhan 2013)

A. sinensis is most commonly administered as a multi-ingredient preparation (often combined with Astragalus membranaceus), making both attribution of effect and comparison of traditional Chinese medicine applications with Western medicine difficult.(Hook 2014, Lin 2017)


In vitro and in vivo animal experiments suggest that A. sinensis possesses angiogenic activity. Experiments on human periodontal and bone tissue have been conducted.(Lam 2008, Zhao 2008, Yang 2002) The clinical relevance of these findings has yet to be confirmed.


An aqueous extract of A. sinensis inhibited IgE-antibody production in a mouse model of atopic allergy. The extract was active orally and the activity was retained on dialysis, indicating that it was caused by high molecular weight components of the extract.(Sung 1982) The simple lactone ligustilide is thought to be a major bioactive principle of dong quai. Its antiasthmatic action was studied in guinea pigs.(Tao 1984)

Anti-inflammatory effects

Chemical constituents from related species have demonstrated anti-inflammatory effects in vitro and in animal experiments.(Kosuge 1985, Ko 1992, Guh 1996, Chen 1995, Liu 1998, Magdalou 2015) Histamine antagonism and analgesic properties have also been demonstrated.(Chen 1995, Kimura 1997) Several isolated compounds of A. sinensis have demonstrated COX-2 enzyme inhibitory activity in vitro.(Lv 2018) In rats, a medium-dose (0.176 mL/kg/day) of volatile oils of A. sinensis was observed to significantly improve recovery to an LPS-induced inflammatory response compared to untreated LPS controls (P<0.05).(Hua 2018) Similarly, LPS-induced inflammation in neuronal cells lines was significantly mitigated by Angelica polysaccharides via reducing apoptosis and improving numerous inflammatory cytokines and regulatory pathways.(Zhou 2019)


An in vitro study demonstrated a protective effect of A. sinensis on hydrogen peroxide-induced endothelial cell damage.(Hou 2004)


Ligustilide and the related butylidenephthalide and butylphthalide were found to have antispasmodic activity against rat uterine contractions and other smooth muscle systems. The compounds were characterized as nonspecific antispasmodics with a mechanism different from that of papaverine.(Ko 1980)


In vitro experiments evaluating A. sinensis extracts found induced apoptosism activity against cervical and hepatocellular carcinoma and leukemia cell lines(Chen 2007, Chae 2004) and inhibitory actions against a number of tumors.(Lee 2006, Tsai 2005)

A large, prospective observational study in postmenopausal women during a 7-year period found that dong qui use was not associated with an increased risk of breast cancer (hazards ratio 1.27 [95% confidence interval, 0.76 to 2.13]), but the number of patients reporting use was less than 500 out of a study population of more than 30,000 patients.(Brasky 2010)


The furocoumarin phellopterin has been characterized as a competitive partial agonist of central benzodiazepine receptors by gamma-aminobutyic acid (GABA) and TBPS shift assays(Dekermendjian 1996) and to bind with high affinity to benzodiazepine receptors in vitro; however, other closely related furocoumarins were weaker or inactive.(Bergendorff 1997) The ligustilide and butylidenephthalide constituents of Japanese angelica root may exert central noradrenergic or GABA activity.(Matsumoto 1998)

Female reproductive system disorders

Animal data

In vivo animal studies suggest that the basis for dong quai use in dysmenorrhea lies in its action of increasing excitability of the uterus; the rhythm of contraction changed from fast, weak, and irregular to slow, strong, and more regular. It has been postulated that the antispasmodic effects of dong quai are related to the volatile oil constituents ligustilide, butylidenephthalide, and butylphthalide, while the uterine-stimulant effect is due to the water-soluble components.(Ko 1980)

Clinical data

Premenstrual syndrome/Dysmenorrhea

Limited clinical trials have been conducted in settings other than China, and those for which efficacy is suggested often utilise multi-ingredient preparations. Ethnic differences in hormonal levels and menopausal symptoms may account for variation in attribution of effect. Reviews suggest evidence for effect in dysmenorrhea exists; however studies included were of short duration and low quality.(Hook 2014)

Menopausal vasomotor symptoms

Randomized, double-blind, placebo-controlled trials of A. sinensis as a single agent and in combination found no difference for dong quai over placebo for menopausal vasomotor symptoms.(Haines 2008, Hirata 1997, Menopause 2004, Cheema 2007) No effect on endometrial thickness or on the level of estradiol or estrone was found in a trial of dong quai alone. The study material was standardized for ferulic acid content.(Hirata 1997, Hook 2014) In addition, Chinese traditional medicine does not recommend the use of dong quai alone, but rather in combination with other plant extracts.(Menopause 2004) The North American Menopause Society concludes that dong quai is no more effective than placebo and that data on estrogenic activity are inconclusive.(Menopause 2004) The Society of Obstetricians and Gynaecologists of Canada revised clinical practice guidelines (2021) on managing menopausal vasomotor symptoms note that safety and efficacy data are insufficient to recommend dong quai root and that safety concerns exist regarding cancer risk and anticoagulant interactions.(Yuksel 2021) The Endocrine Society clinical practice guidelines for the treatment of symptoms of the menopause (2015) recommend counseling patients on the lack of consistent evidence for benefit of complementary medicine therapies, including dong quai, as an alternative nonhormonal therapy for vasomotor symptoms (weak recommendation; low quality evidence).(Stuenkel 2015) The North American Menopause Society position statement for nonhormonal management of menopause-associated vasomotor symptoms (2015) states that dong quai does not appear to be effective for vasomotor symptoms plus a number of safety concerns exist (eg, photosensitization, anticoagulation, possible carcinogenicity). Additionally, it should be used in combination with other botanicals to promote thserapeutic synergies (Level II).(NAMS 2015)

Despite evidence that dong quai does not bind to estrogen receptors, experiments have demonstrated the ability of A. sinensis extracts to stimulate breast cancer cells lines (MCF-7 and BT-20). Considering the lack of evidence for effect on menopausal vasomotor symptoms, dong quai should not be used by menopausal women with breast cancer.(Kronenberg 2002, Haimov-Kochman 2008, Haimov-Kochman 2005, Lau 2005)

A small pilot study conducted on the effects of dong quai on hot flashes in prostate cancer patients receiving lutenizing hormone-releasing hormone therapy found no significant benefit compared with placebo for the frequency, severity, or duration of hot flashes. There was also no difference between dong quai and placebo groups for prostate-specific antigen levels and digital rectal examination results during the 3-month study.(Al-Bareeq 2010)


Among women with either menstrual migraine or simple migraine without aura, a combination preparation of soy isoflavones, black cohosh, and dong quai taken daily for 24 weeks decreased the frequency and severity of attacks.(Burke 2002) Dong quai has not been investigated alone for its effect in this indication.


Nephrotic syndrome has been traditionally treated with A. senensis and Astragalus mongholicus by Chinese practitioners. Animal models demonstrated an efficacy with these plant extracts similar to that of enalapril in preventing renal fibrosis and limiting the deterioration of renal function.(Wang 2004)


Several forms of the plant exist and dosages vary widely: crude root extract by decoction ranges from 3 to 15 g/day; powdered root, 1 to 2 g 3 times a day; and tablets 500 mg up to 6 times a day.

In a clinical trial investigating use in menopause, dong quai 4.5 g was administered daily for 24 weeks. In combination, dong quai 100 mg standardized to 1% ligustilide was similarly used daily.Burke 2002, Hirata 1997, Haimov-Kochman 2005, Lau 2005

The content of A. sinensis in some commercially available preparations has been questioned.Hook 2014

Pregnancy / Lactation

Avoid use.Brinker 1998 Uterine stimulant and relaxant activity have been reported with A. sinensis, while a related species, Angelica archangelica L., was a reported abortifacient and affected the menstrual cycle.Ko 1980


Studies indicate A. sinensis extracts increase CYP2D6 and CYP3A4 activity in the liver of rats, with potential for herb-drug interactions.(Hook 2014)

Agents with antiplatelet properties: Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of agents with antiplatelet properties. Bleeding may occur. Consider therapy modification.(Mousa 2010, Stanger 2012, Ulbricht 2008, Tsai 2013)

Aminolevulinic acid (systemic): Photosensitizing agents may enhance the photosensitizing effect of aminolevulinic acid (systemic). Avoid combination. (Alacare March 2015, Ameluz May 2016, Drucker 2011, Gleolan June 2017, Ladner 2001, Lankerani 2004, Levulan March 2010, Naldi 1999)

Aminolevulinic acid (topical): Photosensitizing agents may enhance the photosensitizing effect of aminolevulinic acid (topical). Monitor therapy. (Alacare March 2015, Ameluz May 2016, Drucker 2011, Ladner 2001, Lankerani 2004, Levulan March 2010, Naldi 1999)

Anticoagulants: Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of anticoagulants. Bleeding may occur. Consider therapy modification.(Mousa 2010, Spolarich 2007, Stanger 2012, Ulbricht 2008, Tsai 2013)

Herbs (anticoagulant/antiplatelet properties): Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of other herbs (anticoagulant/antiplatelet properties). Bleeding may occur. Consider therapy modification.(Mousa 2010, Spolarich 2007, Stanger 2012, Ulbricht 2008, Tsai 2013)

Nonsteroidal anti-inflammatory agents: Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of nonsteroidal anti-inflammatory agents. Bleeding may occur. Consider therapy modification.(Mousa 2010, Spolarich 2007, Stanger 2012, Ulbricht 2008, Tsai 2013)

Porfimer: Photosensitizing agents may enhance the photosensitizing effect of porfimer. Monitor therapy.(Drucker 2011, Lankerani 2004, Naldi 1999, Photofrin June 2011)

Salicylates: Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of salicylates. Bleeding may occur. Consider therapy modification.(Mousa 2010, Spolarich 2007, Stanger 2012, Tsai 2013, Ulbricht 2008)

Thrombolytic agents: Herbs (anticoagulant/antiplatelet properties) may enhance the adverse/toxic effect of thrombolytic agents. Bleeding may occur. Consider therapy modification.(Mousa 2010, Spolarich 2007, Stanger 2012, Ulbricht 2008, Tsai 2013)

Verteporfin: Photosensitizing agents may enhance the photosensitizing effect of verteporfin. Monitor therapy.(Drucker 2011, Lankerani 2004, Naldi 1999, Visudyne June 2012)

Warfarin: Dong quai may enhance the anticoagulant effect of warfarin. Monitor therapy.(Page 1999)

Adverse Reactions

Furanocoumarins, such as bergapten and psoralen, have been widely studied for their photoactivated toxicity; however, only A. gigas (Korean angelica) has caused photodermatitis. The risk of phototoxicity should be correlated with the content of specific toxic furocoumarins; in the case of A. sinensis, the risk appears to be limited.Kronenberg 2002, Haimov-Kochman 2005, Hann 1991, Leung 1996

Fever was reported in a clinical trial.Page 1999

Hypertension has been reported with the use of this herb.Jalili 2013

A case of gynaecomastia was reported, but causality is unclear.Goh 2001 The possibility of dong quai tablet contamination has been raised.Fugh-Berman 2003, Kiong 2001

In the 2016 Scientific Statement by the American Heart Association regarding drugs that may cause or exacerbate heart failure, dong quai has been recognized as a product with anticoagulant effects which may increase bleeding risk when used with anticoagulants. The guidance noted that naturoceuticals are not recommended for the management of heart failure symptoms or for the secondary prevention of cardiovascular events, and that nutritional supplements are not recommended for the treatment of heart failure [Low-quality; Limited].Page 2016


To date, phytoestrogen-containing herbs have not been associated with the negative health effects seen with synthetic estrogen. However, use with caution in individuals on hormone replacement therapy, oral contraceptives, or those with a history of estrogen-dependent tumors, endometrial cancer, thromboembolic disease, or stroke.Piersen 2003, Menopause 2004

The oral median lethal dose (LD50) of concentrated dong quai extract has been estimated at 100 mg/kg. Intravenous administration of 1 mL/kg of the essential oil in rabbits resulted in hypotension and respiratory suppression. Phenol and certain furocoumarin groups found in dong quai have demonstrated cytotoxic properties.Yang 2002

Index Terms

  • Angelica acutiloba Kitagawa
  • Angelica archangelic L.
  • Angelica dahurica (Fisch.) Benth. et. Hook. f.
  • Angelica dahurica var. formosana (Boiss.) Shan et Yuan
  • Angelica gigas Nakai
  • Angelica polymorpha var. sinensis (Oliv.)
  • Angelica pubescens Maxim. f. biserrata Shan et Yuan
  • Umbelliferae



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Ameluz (aminolevulinic acid) gel [prescribing information]. Wakefield, MA: Biofrontera Inc; May 2016.
Al-Bareeq RJ, Ray AA, Nott L, Pautler SE, Razvi H. Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial. Can Urol Assoc J. 2010;4(1):49-53.20165579
Baba K, Matsuyama Y, Kozama M. Studies on coumarins from the root of Angelica pubescens Maxim. IV. Structures of angelol-type prenylcoumarins. Chem Pharm Bull. 1982;30(6):2025-2035.
Bergendorff O, Dekermendjian K, Nielsen M, et al. Furanocoumarins with affinity to brain benzodiazepine receptors in vitro. Phytochemistry. 1997;44(6):1121-1124.9055449
Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1696-1708.20615886
Brinker FJ. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications; 1998.
Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother. 2002;56(6):283-288.12224599
Chae HJ, Park KM, Lee GY, et al. Je-chun-jun induced apoptosis of human cervical carcinoma HeLa cells. Acta Pharmacol Sin. 2004;25(10):1372-1379.15456542
Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet. 2007;276(5):463-469.17593379
Chen QC, Lee J, Jin W, et al. Cytotoxic constituents from Angelicae sinensis radix. Arch Pharma Res. 2007;30(5):565-569.17615675
Chen XP, Li W, Xiao XF, Zhang LL, Liu CX. Phytochemical and pharmacological studies on Radix Angelica sinensis. Chin J Nat Med. 2013;11(6):577-87.24345498
Chen Y, et al. Analysis of the composition of Angelica sinensis – determination of the essential oil composition by capillary column GC/MS. Gaodeng Xuexiao Huaxue Xuebao. 1984;5:125.6322594
Chen Y, Tsai HY, Wu TS. Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Med. 1995;61(1):2-8.
Choy Y, Leung KN, Cho CS, Wong CK, Pang PK. Immunopharmacological studies of low molecular weight polysaccharide from Angelica sinensis. Am J Chin Med. 1994;22(2):137-145.7992813
Dekermendjian K, Ai J, Nielsen M, et al. Characterisation of the furanocoumarin phellopterin as a rat brain benzodiazepine receptor partial agonist in vitro. Neurosci Lett. 1996;219:151-1548971802
Dong quai (angelica sinesis [oliv.] Dies), Chinese angelica. Accessed February 26, 2009.
Drucker AM, Rosen CF. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug Saf. 2011;34(10):821-837.21879777
Fugh-Berman A. "Bust enhancing" herbal products. Obstet Gynecol. 2003;101(6):1345-1349.12798545
Gleolan (aminolevulinic acid) for oral solution [prescribing information]. Dessau-Rosslau, Germany: IDT Biologika GmbH; June 2017.
Goh SY, Loh KC. Gynaecomastia and the herbal tonic "Dong Quai". Singapore Med J. 2001;42(3):115-116.11405562
Guh J, Yu SM, Ko FN, Wu TS, Teng CM. Antiproliferative effect in rat vascular smooth muscle cells by osthole, isolated from Angelica pubescens. Eur J Pharmacol. 1996;298(2):191-197.8867108
Hajirahimkhan A, Dietz BM, Bolton JL. Botanical modulation of menopausal symptoms: mechanisms of action? Planta Med. 2013;79(7):538-53.23408273
Haimov-Kochman R, Brzezinski A, Hochner-Celnikier D. Herbal remedies for menopausal symptoms: are we cautious enough? Eur J Contracept Reprod Health Care. 2008;13(2):133-137.18465474
Haimov-Kochman R, Hochner-Celnikier D. Hot flashes revisited: pharmacological and herbal options for hot flashes management. What does the evidence tell us? Acta Obstet Gynecol Scand. 2005;84(10):972-979.18465474
Haines CJ, Lam PM, Chung TK, Cheng KF, Leung PC. A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women. Climacteric. 2008;11(3):244-251.18568789
Hann S, Park YK, Im S, Byun SW. Angelica-induced phytophotodermatitis. Photodermatol Photoimmunol Photomed. 1991;8(2):84-85.1756118
Hata K, Kozawa M, Ikeshiro Y. [On the coumarins of the roots of Angelica polymorpha Maxim. [in Japanese] Yakugaku Zasshi. 1967;87(4):464-465.5624147
Hua YL, Ma Q, Zhang XS, Yao WL, Ji P, Hu JJ, Wei Ym. Urinary metabolomics analysis reveals the effect of volatile oil from Angelica sinensis on LPS-induced inflammation rats. Biomed Chromatogr. 2019;33(2):e4402.30255631
Hirata JD, Swierz LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril. 1997;68(6)981-986.9418683
Hon PM, Lee CM, Choang TF, Chui KY, Wong HN. A ligustilide dimer from Angelica sinensis. Phytochemistry. 1990;29(4):1189-1191.
Hook IL. Danggui to Angelica sinensis root: are potential benefits to European women lost in translation? A review. J Ethnopharmacol. 2014;152(1):1-13.24365638
Hou YZ, Zhao GR, Yang J, Yuan YJ, Zhu GG, Hiltunen R. Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Life Sci. 2004;75(14):1775-1786.15268976
Jalili J, Askeroglu U, Alleyne B, Guyuron B. Herbal products that may contribute to hypertension. Plast Reconstr Surg. 2013;131(1):168-173
Ji SG, Chai YF, Wu YT, et al. Determination of ferulic acid in Angelica sinensis and Chuanxiong by capillary zone electrophoresis. Biomed Chromatogr. 1999;13(5):333-334.10425022
Kimura Y, Okuda Hl. Histamine-release effectors from Angelica dahurica var. dahurica root. J Nat Prod. 1997;60(3):249-251.
Kiong HN. Article: gynaecomastia and the herbal tonic "Dong Quai". Singapore Med J. 2001;42(6):286-287.11547970
Ko FN, Wu TS, Lion MJ, Huang TF, Teng CM. Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. Eur J Pharmacol. 1992;219(1):29-34.1327835
Ko WC. A newly isolated antispasmodic - butylidenephthalide. Jpn J Pharmacol. 1980;30(1):85-91.7401411
Kosuge T, Yokota M, Sugiyama K, et al. Studies on bioactive substances in crude drugs used for arthritic diseases in traditional Chinese medicine. II. Isolation and identification of an anti-inflammatory and analgesic principle from the root of Angelica pubescens Maxim. Chem Pharm Bull. 1985;33(12):5351-5354.3879591
Kozawa M, Baba K, Matsuyama Y, Hata K. Studies on coumarins from the root of Angelica pubescens Maxim. III. Structures of various coumarins including angelin, a new prenylcoumarin. Chem Pharm Bull. 1980;28(6):1782-1787.
Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002;137(10):805-813.12435217
Kwon YS, Kobayashi A, Kajiyama S, Kawazu K, Kanzaki H, Kim CM. Antimicrobial constituents of Angelica dahurica roots. Phytochemistry. 1997;44(5)887-889.
Ladner DP, Klein SD, Steiner RA, Walt H. Synergistic toxicity of delta-aminolaevulinic acid-induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant. Br J Dermatol. 2001;144(4):916-918.11298571
Lam HW, Lin HC, Lao SC, et al. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. J Cell Biochem. 2008;103(1):195-211.17497682
Lankerani L, Baron ED. Photosensitivity to exogenous agents. J Cutan Med Surg. 2004;8(6):424-431.15988550
Lau CB, Ho TC, Chan TW, Kim SC. Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate? Menopause. 2005;12(6):734-740.16278617
Lee WH, Jin TS, Tsai WC, et al. Biological inhibitory effects of the Chinese herb danggui on brain astrocytoma. Pathobiology. 2006;73(3):141-148.
Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Foods, Drugs, and Cosmetics. New York, NY: Wiley; 1996:32-3.
Levulan (aminolevulinic acid) topical solution [prescribing information]. Wilmington, MA: DUSA Pharmaceuticals Inc; March 2010.
Lin HQ, Gong AG, Wang HY, et al. Danggui Buxue Tang (Astragali Radix and Angelicae Sinensis Radix) for menopausal symptoms: A review. J Ethnopharmacol. 2017;199:205-210.28163116
Liu J, Zschocke S, Reininger E, Bauer R. Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase. Planta Med. 1998;64(6):525-529.9741298
Lv JL, Zhang LB, Guo LM. Phthalide dimers from Angelica sinensis and their COX-2 inhibition activity. Fitoterapia. 2018;129:102-107.29935258
Magdalou J, Chen LB, Wang H, et al. Angelica sinensis and osteoarthritis: a natural therapeutic link? Biomed Mater Eng. 2015;25(1 suppl):179-86.25538068
Matsumoto K, Kohno S, Ojima K, et al. Effects of methylenechloride-soluble fraction of Japanese angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in group-housed and socially isolated mice. Life Sci. 1998;62(23):2073-2082.9627086
Mizukami H. Amplification and sequence of a 5s-rRNA gene spacer region from the crude drug "angelica root". Biol Pharm Bull. 1995;18(9):1299-1301.8845829
Mousa SA. Antithrombotic effects of naturally derived products on coagulation and platelet function, Methods Mol Biol, 2010;663:229-240.20617421
Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol. 1999;48(6):839-846.10594488
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;22(11):1155-1172.26382310
North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause. 2004;11(1):11-33.14716179
Okuyama T, Takata M, Nishino H, Nishino A, Takayasu J, Iwashima A. Studies on the antitumor-promoting activity of naturally occurring substances. II. Inhibition of tumor-promoter-enhanced phospholipid metabolism by umbelliferous materials. Chem Pharm Bull. 1990;38(4):1084-1086.2379282
Page RL II, Lawerence JD. Potentiation of warfarin by dong quai. Pharmacotherapy. 1999;19(7):870-876.
Page RL 2nd, O'Bryant CL, Cheng D, et al; American Heart Association Clinical Pharmacology and Heart Failure and Transplantation Committees of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016;134(6):e32-69.27400984
Photofrin (porfimer) [prescribing information]. Bannockburn, IL: Pinnacle Biologics Inc. June 2011.
Piersen CE. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr Cancer Ther. 2003;2(2):120-138. Review.15035899
Sheu Sj, Ho VS, CHen YP, Hsu HY. Analysis and processing of Chinese herbal drugs; VI. The study of Angelicae radix. Planta Med. 1987;53(4):377-378.3671555
Spolarich AE, Andrews L, “An Examination of the Bleeding Complications Associated with Herbal Supplements, Antiplatelet and Anticoagulant Medications,” J Dent Hyg, 2007, 81(3):67.17908423
Stanger MJ, Thompson LA, Young AJ, et al. Anticoagulant activity of select dietary supplements. Nutr Rev. 2012;70(2):107-117.22300597
Stuenkel CA, Davis SR, Gompel A, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011.26444994
Sung C, Baker AP, Holden DA, Smith WJ, Chakrin LW. Effect of extracts of Angelica polymorpha on reaginic antibody production. J Nat Prod. 1982;45(4):398-406.7130985
Tang W, Eisenbrand G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine. Berlin: Springer-Verlag; 1992:113-125.
Tani S, Fujiwara H, Kato A. Studies on constituents of Angelica dahurica. II. Identification of gamma-nonalactone and gamma-decalactone by GC and GC/MS as a part of the odor components. J Nat Prod. 1984;47(4):734.
Tao JY, Ruan YP, Mei QB, et al. [Studies on the antiasthmatic action of ligustilide of dang-gui, Angelica sinensis (Oliv.) Diels. [in Chinese] 1984;19(8):561-565.6536161
Tsai HH, Lin HW, Lu YH, et al. A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines. PLoS One. 2013;8(5):e64255.23671711
Tsai NM, Lin SZ, Lee CC, et al. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Clin Cancer Res. 2005;11(9):3475-3484.15867250
Ulbricht C, Chao W, Costa D, et al. Clinical evidence of herb-drug interactions: a systematic review by the Natural Standard Research Collaboration. Curr Drug Metab. 2008;9(10):1063-1120.19075623
Visudyne (verteporfin) [prescribing information]. Rochester, MI: JHP Pharmaceuticals LLC; June 2012.
Wang H, Li J, Yu L, Zhao Y, Ding W. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sci. 2004;74(13):1645-1658.14738908
Wei WL, Zeng R, Gu CM, et al. Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis. J Ethnopharmacol. 2016;190:116-41.27211015
Yang Q, Populo SM, Zhang J, Yang G, Kodama H. Effect of Angelica sinensis on the proliferation of human bone cells. Clin Chim Acta. 2002;324(1-2):89-97.
Yuksel N, Evaniuk D, Huang L, et al. Guideline No. 422a: Menopause: Vasomotor symptoms, prescription therapeutic agents, complementary and alternative medicine, nutrition, and lifestyle [published correction appears in J Obstet Gynaecol Can. 2022;44(2):227]. J Obstet Gynaecol Can. 2021;43(10):1188-1204.e1. doi:10.1016/j.jogc.2021.08.00334390867
Zhao H, Alexeev A, Sharma V, Guzman LD, Bojanowski K. Effect of SBD.4A – a defined multicomponent preparation of Angelica sinensis – in periodontal regeneration models. Phytother Res. 2008;22(7):923-928.18389473
Zhou Y, Guo X, Chen W, Liu J. Angelica polysaccharide mitigates lipopolysaccharide-evoked inflammatory injury by regulating microRNA-10a in neuronal cell line HT22. Artif Cells Nanomed Biotechnol. 2019;42(1):3194-3201.31353963
Zschocke S, Liu J-H, Stuppner H, Bauer R. Comparative study of roots of Angelica sinensis and related Umbelliferous drugs by thin layer chromatography, high-performance liquid chromatography, and liquid chromatography-mass spectrometry. Phytochem Anal. 1998;9(6):283-290.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.